Cargando…

Ketogenic diet ameliorates lipid dysregulation in type 2 diabetic mice by downregulating hepatic pescadillo 1

BACKGROUND: Previous reports implied a possible link between PES1 and lipid metabolism. However, the role of PES1 in regulating T2DM related lipid metabolism and the effect of ketogenic diet (KD) on PES1 have not been reported. The aim of present study is to explore the role of PES1 in effects of KD...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jielin, Lu, Yao, Jia, Yajing, Lu, Jing, Jiang, Zhengxuan, Chen, Keyang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722053/
https://www.ncbi.nlm.nih.gov/pubmed/34979900
http://dx.doi.org/10.1186/s10020-021-00429-6
_version_ 1784625451230035968
author Zhou, Jielin
Lu, Yao
Jia, Yajing
Lu, Jing
Jiang, Zhengxuan
Chen, Keyang
author_facet Zhou, Jielin
Lu, Yao
Jia, Yajing
Lu, Jing
Jiang, Zhengxuan
Chen, Keyang
author_sort Zhou, Jielin
collection PubMed
description BACKGROUND: Previous reports implied a possible link between PES1 and lipid metabolism. However, the role of PES1 in regulating T2DM related lipid metabolism and the effect of ketogenic diet (KD) on PES1 have not been reported. The aim of present study is to explore the role of PES1 in effects of KD on diabetic mice and its mediated mechanism. METHODS: Male C57BL/6J and KKA(y) mice were fed with standard diet (SD) and KD, respectively. Simultaneously, McArdle 7777 cells were treated by β-hydroxybutyric acid (β-HB), Pes1 siRNA or Pes1 overexpression plasmid, respectively. Additionally, liver-conditional knockout (CKO) of Pes1 in vivo was applied. RESULTS: Hepatic PES1 expression in diabetic mice was markedly increased, which was suppressed by KD feeding with an accompanying reduction of hepatic and plasma triglycerides (TG). In mice with CKO of Pes1, the protein levels of p300, SREBP1c, FASN, SCD1, Caspase1, NLRP3 and GSDMD were dramatically downregulated in livers, and the plasma and hepatic TG, IL-1β and IL-18 were decreased as well. The similar outcomes were also observed in β-HB and Pes1 knockdown treated hepatocytes. By contrast, Pes1 overexpression in cultured hepatocytes showed that these levels were significantly enhanced, which were, however reduced under β-HB treatment. Mechanistically, we discovered that β-HB decreased CHOP binding to the Pes1 promoters, resulting in the downregulation of PES1, thereby reducing PES1 binding to p300 and Caspase1 promoters. The inhibition of p300 and Caspase1 expression elicited the dramatic suppression of acetylation of SREBP1c via its interaction with p300, and the decreased GSDMD levels. Besides, knockdown of Caspase1 also alleviated the TG levels in cultured hepatocytes. CONCLUSION: KD may improve lipid dysregulation in type 2 diabetic mice by downregulating hepatic PES1 expression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-021-00429-6.
format Online
Article
Text
id pubmed-8722053
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-87220532022-01-05 Ketogenic diet ameliorates lipid dysregulation in type 2 diabetic mice by downregulating hepatic pescadillo 1 Zhou, Jielin Lu, Yao Jia, Yajing Lu, Jing Jiang, Zhengxuan Chen, Keyang Mol Med Research Article BACKGROUND: Previous reports implied a possible link between PES1 and lipid metabolism. However, the role of PES1 in regulating T2DM related lipid metabolism and the effect of ketogenic diet (KD) on PES1 have not been reported. The aim of present study is to explore the role of PES1 in effects of KD on diabetic mice and its mediated mechanism. METHODS: Male C57BL/6J and KKA(y) mice were fed with standard diet (SD) and KD, respectively. Simultaneously, McArdle 7777 cells were treated by β-hydroxybutyric acid (β-HB), Pes1 siRNA or Pes1 overexpression plasmid, respectively. Additionally, liver-conditional knockout (CKO) of Pes1 in vivo was applied. RESULTS: Hepatic PES1 expression in diabetic mice was markedly increased, which was suppressed by KD feeding with an accompanying reduction of hepatic and plasma triglycerides (TG). In mice with CKO of Pes1, the protein levels of p300, SREBP1c, FASN, SCD1, Caspase1, NLRP3 and GSDMD were dramatically downregulated in livers, and the plasma and hepatic TG, IL-1β and IL-18 were decreased as well. The similar outcomes were also observed in β-HB and Pes1 knockdown treated hepatocytes. By contrast, Pes1 overexpression in cultured hepatocytes showed that these levels were significantly enhanced, which were, however reduced under β-HB treatment. Mechanistically, we discovered that β-HB decreased CHOP binding to the Pes1 promoters, resulting in the downregulation of PES1, thereby reducing PES1 binding to p300 and Caspase1 promoters. The inhibition of p300 and Caspase1 expression elicited the dramatic suppression of acetylation of SREBP1c via its interaction with p300, and the decreased GSDMD levels. Besides, knockdown of Caspase1 also alleviated the TG levels in cultured hepatocytes. CONCLUSION: KD may improve lipid dysregulation in type 2 diabetic mice by downregulating hepatic PES1 expression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s10020-021-00429-6. BioMed Central 2022-01-03 /pmc/articles/PMC8722053/ /pubmed/34979900 http://dx.doi.org/10.1186/s10020-021-00429-6 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Zhou, Jielin
Lu, Yao
Jia, Yajing
Lu, Jing
Jiang, Zhengxuan
Chen, Keyang
Ketogenic diet ameliorates lipid dysregulation in type 2 diabetic mice by downregulating hepatic pescadillo 1
title Ketogenic diet ameliorates lipid dysregulation in type 2 diabetic mice by downregulating hepatic pescadillo 1
title_full Ketogenic diet ameliorates lipid dysregulation in type 2 diabetic mice by downregulating hepatic pescadillo 1
title_fullStr Ketogenic diet ameliorates lipid dysregulation in type 2 diabetic mice by downregulating hepatic pescadillo 1
title_full_unstemmed Ketogenic diet ameliorates lipid dysregulation in type 2 diabetic mice by downregulating hepatic pescadillo 1
title_short Ketogenic diet ameliorates lipid dysregulation in type 2 diabetic mice by downregulating hepatic pescadillo 1
title_sort ketogenic diet ameliorates lipid dysregulation in type 2 diabetic mice by downregulating hepatic pescadillo 1
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8722053/
https://www.ncbi.nlm.nih.gov/pubmed/34979900
http://dx.doi.org/10.1186/s10020-021-00429-6
work_keys_str_mv AT zhoujielin ketogenicdietameliorateslipiddysregulationintype2diabeticmicebydownregulatinghepaticpescadillo1
AT luyao ketogenicdietameliorateslipiddysregulationintype2diabeticmicebydownregulatinghepaticpescadillo1
AT jiayajing ketogenicdietameliorateslipiddysregulationintype2diabeticmicebydownregulatinghepaticpescadillo1
AT lujing ketogenicdietameliorateslipiddysregulationintype2diabeticmicebydownregulatinghepaticpescadillo1
AT jiangzhengxuan ketogenicdietameliorateslipiddysregulationintype2diabeticmicebydownregulatinghepaticpescadillo1
AT chenkeyang ketogenicdietameliorateslipiddysregulationintype2diabeticmicebydownregulatinghepaticpescadillo1